Servicio de Virología Molecular, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
PLoS One. 2012;7(2):e31928. doi: 10.1371/journal.pone.0031928. Epub 2012 Feb 24.
To study the causes for the lack of clinical progression in a superinfected HIV-1 LTNP elite controller patient.
We studied host genetic, virological and immunological factors associated with viral control in a SI long term non progressor elite controller (LTNP-EC). The individual contained both viruses and maintained undetectable viral loads for >20 years and he did not express any of the described host genetic polymorphisms associated with viral control. None of four full-length gp160 recombinants derived from the LTNP-EC replicated in heterologous peripheral blood mononuclear cells. CTL responses after SI were maintained in two samples separated by 9 years and they were higher in breadth and magnitude than responses seen in most of 250 treatment naïve patients and also 25 controller subjects. The LTNP-EC showed a neutralization response, against 4 of the 6 viruses analyzed, superior to other ECs.
The study demonstrated that a strong and sustained cellular and humoral immune response and low replicating viruses are associated with viral control in the superinfected LTNP-EC.
研究超级感染 HIV-1 长期非进展性 LTNP 精英控制者患者缺乏临床进展的原因。
我们研究了与病毒控制相关的宿主遗传、病毒学和免疫学因素,该个体同时携带两种病毒,并保持 20 多年的病毒载量无法检测到,他没有表达任何与病毒控制相关的描述性宿主遗传多态性。从 LTNP-EC 获得的四个全长 gp160 重组体均不能在异源外周血单核细胞中复制。在相隔 9 年的两个样本中,SI 后的 CTL 反应得到了维持,其广度和强度均高于 250 名未经治疗的患者和 25 名对照组患者的反应。LTNP-EC 对分析的 6 种病毒中的 4 种表现出优于其他 EC 的中和反应。
该研究表明,强大而持续的细胞和体液免疫反应以及低复制病毒与超级感染 LTNP-EC 中的病毒控制有关。